Illumina Inc. (ILMN) announced Tuesday morning that it has entered into an agreement with Thermo Fisher Scientific (TMO) that will allow Illumina to sell Ion AmpliSeq technology directly to its customers.
Illumina gapped open sharply higher this morning and is now up 12.22 at $239.28. The stock has broken out of over a 1-month trading range and has set a new high for the year.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com